Dr. Kelly M McMasters, MD
Claim this profileArea of expertise
Melanoma
Kelly M McMasters, MD has run 1 trial for Melanoma. Some of their research focus areas include:
Clinical Trials Kelly M McMasters, MD is currently running
More about Kelly M McMasters, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Kelly M McMasters, MD has experience with
- Beta-Glucan
Breakdown of trials Kelly M McMasters, MD has run
Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kelly M McMasters, MD specialize in?
Kelly M McMasters, MD focuses on Melanoma and other conditions. In particular, much of their work with Melanoma has involved Stage III patients, or patients who are Stage IV.
Is Kelly M McMasters, MD currently recruiting for clinical trials?
Yes, Kelly M McMasters, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Kelly M McMasters, MD has studied deeply?
Yes, Kelly M McMasters, MD has studied treatments such as Beta-Glucan.
What is the best way to schedule an appointment with Kelly M McMasters, MD?
Apply for one of the trials that Kelly M McMasters, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.